• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Mounjaro

Eli Lilly Lilly
Pharma

Lilly warns of 'impurity' in some compounded tirzepatide drugs

Eli Lilly warned it has “uncovered significant levels of an impurity” in certain compounded tirzepatide products that include vitamin B12.
Fraiser Kansteiner Mar 12, 2026 10:00am
David Ricks Lilly CEO Eli Lilly CEO

Lilly CEO David Ricks collects $36.7M pay package for 2025

Mar 9, 2026 3:20pm
Eli Lilly Lilly

Lilly sees big sales increase in 2026 despite pricing pressures

Feb 4, 2026 2:55pm
Drug Pricing

Biopharma industry gathers momentum in Q3

Nov 14, 2025 9:28am
Ozempic Wegovy

Emcure partners with Novo to increase access to Wegovy in India

Nov 10, 2025 11:47am
Eli Lilly

Lilly blows out tirzepatide sales expectations, raises guidance

Oct 30, 2025 10:39am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings